FDMT · 4D Molecular Therapeutics, Inc. · Debt
Market Cap
$950.61M
Shares
72.18M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1650648
CUSIP
35104E100
13F (30d)
64 filings
64 filers
Visit website
Investor relations